FDA approves oral disease-modifying drug for multiple sclerosis
The FDA recently approved teriflunomide for the treatment of patients with relapsing forms of multiple
sclerosis.
Source: Modern Medicine - Category: Journals (General) Source Type: news
More News: General Medicine | Multiple Sclerosis